• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Catalog Number 08D06-74
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/11/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, architect )b)(6) tp, list 8d06-74, that has a similar product distributed in the us, list number 8d06-31/-41.Complete entry = (b)(6).No further information was provided.
 
Event Description
The customer obtained a false (b)(6) tp result for a (b)(6) female with a history of (b)(6) infection.Sample id (b)(6) generated a (b)(6) s/co on the architect and negative on rpr.The sample generated positive results on roche 4.54 s/co, autobio 10.16 s/co, colloidal gold rapid test strip and tppa.While troubleshooting the issue the customer also sent the sample to another hospital which tested the sample on an abbott platform and generated a non-reactive results of 0.98 s/co.No impact to patient management was reported.
 
Manufacturer Narrative
H6 health effect impact code: f26.H6 component code: g01003.D8 was this device serviced by a third party? no.The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and testing of a retained kit of the complaint lot number.Return testing was not completed as returns were not available.Review of complaint activity and trending reports did not identify any issues or trends related to the complaint issue.Device history record review for the lot did not identify any non-conformances or deviations.A retained kit of the complaint lot was tested in a sensitivity setup.All specifications were met and no false non-reactive results were obtained, indicating that the sensitivity performance is acceptable.Based on our investigation, no systemic issue or deficiency of the architect syphilis tp reagent lot was identified.D4 expiration date was changed from 1/21/2021 to 1/20/2021 due to a typo.D10 was changed from yes to no since the device was not available.
 
Manufacturer Narrative
This follow up is submitted to populate fields d8 and/or h6 with data that had previously been provided in field h10.There is no change to the content of the data.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT SYPHILIS TP REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11208566
MDR Text Key243144790
Report Number3002809144-2021-00045
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K153730
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/21/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/20/2021
Device Catalogue Number08D06-74
Device Lot Number12692BE01
Was Device Available for Evaluation? Yes
Date Manufacturer Received05/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, ISR53944.; ARC I2K PROC MOD, 03M74-01, ISR53944.
Patient Age38 YR
-
-